Secondary solid cancer screening following hematopoietic cell transplantationYoshihiro Inamoto, Navneet S. Majhail, Maxim Norkin et al.|Bone Marrow Transplantation|2015Cited by 185
Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and OutcomesRachel Phelan, Mukta Arora, Min Chen et al.|Transplantation and Cellular Therapy|2022Cited by 82
Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant ResearchJeffery J. Auletta, Bronwen E. Shaw, Jianqun Kou et al.|Transplantation and Cellular Therapy|2023Cited by 68
Current Trends and Outcomes in Cellular Therapy Activity in the United States, Including Prospective Patient-Reported Outcomes Data Collection in the Center for International Blood and Marrow Transplant Research RegistryRachel Cusatis, Bronwen E. Shaw, Carlos Litovich et al.|Transplantation and Cellular Therapy|2024Cited by 68
Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMTZachariah DeFilipp, Bronwen E. Shaw, Rafael F. Duarte et al.|Biology of Blood and Marrow Transplantation|2016Cited by 64